13/11/2024  11:16:16 Diferencia +0.80 Volumen Bid11:16:20 Ask11:16:20 Capitalización de mecado Dividendo A. P/E Ratio
217.40CHF +0.37% 9,039
Volumen de negocios: 1.96 millones
217.20Volumen de oferta: 38 217.80Tamaño/ Volumen/ Formato de Ask: 40 2.76 mil millonesCHF 0.69% 20.91

Descripción de negocio

Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
 

Consejo de gestión & Consejo de supervisión

CEO
Dr. Achim von Leoprechting
Consejo de gestión
Tania Micki, Andreas Wilhelm, Dr. Wael Yared, Erik Norström, Ingrid Pürgstaller, Ralf Griebel, Ulrich Kanter, Mukta Acharya
Consejo de supervisión
Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Myra Eskes, Matthias Gillner, Monica Manotas
 

Datos de la empresa

Nombre: Tecan Group AG
Dirección: Seestrasse 103,CH-8708 Männedorf
Teléfono: +41-44-922-8111
Fax: +41-44-922-8112
E-mail: info@tecan.com
Internet: www.tecan.com
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: 61.50%
Fecha de OPI: -

Relación con inversores

Nombre: Martin Brändle
IR teléfono: +41-44-922-8430
IR-fax: +41-44-922-8889
IR e-mail: investor@tecan.com

Accionistas mayoritarios

Otros
 
55.70%
Chase Nominees Ltd.
 
12.20%
UBS Fund Management AG
 
5.10%
APG Algemene Pensioen Groep N.V
 
4.50%
BlackRock Inc.
 
4.50%
FIL Limited, Pembroke
 
3.00%
Candriam Luxembourg
 
3.00%
Swisscanto Fondsleitung AG
 
3.00%
Credit Suisse Funds AG
 
3.00%
Otros
 
6.00%